MARKER THERAPEUTICS, INC. (MRKR) Operating cash flow 2016–2025
MARKER THERAPEUTICS, INC. (MRKR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.0MFY2025 · since FY2016: -$6.5M → -$12.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.0M | -10.1% |
| FY2024 | -$10.9M | +33.6% |
| FY2023 | -$16.4M | +39.0% |
| FY2022 | -$27.0M | +1.1% |
| FY2021 | -$27.3M | -36.2% |
| FY2020 | -$20.0M | -9.6% |
| FY2019 | -$18.3M | -26.3% |
| FY2018 | -$14.5M | -71.6% |
| FY2017 | -$8.4M | -29.6% |
| FY2016 | -$6.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice